An observational study to compare adenosine deaminase level among diabetes patients

Vivek Sharma, Sangeeta Bhattacharya, Poornima Dey Sarkar, Gini Garima, Neeraj Gour, Meenakshi Chaudhary


Background: Obesity is a complex disorder that involves some degree of over-consumption1 coupled with a metabolic derangement. As ADA has been putatively associated with inflammation, and adipose tissue inflammation is the hallmark of insulin resistance in obese T2DM patients. This study attempted to compare serum ADA in T2DM subjects.

Methods: This observational cross-sectional study was conducted in the Department of Biochemistry at MGM Medical College and MY Hospital. All the patients and controls were clinically examined, and routine biochemical tests were analyzed for all subjects. ANOVA has been applied to assess the variance between groups.

Results: Mean age of controls was 56.91 years where as mean age in the group of a subject with Obesity with diabetes was 40.91 years and with Obesity without diabetes was 48.10 years. ADA level was more among diabetes patients having obesity than diabetes patients having no obesity and controls.

Conclusions: This is very much evident through this study that ADA may be treated as prognostic predictor of diabetes either linked to obesity or not, though more studies are warranted in same direction to make this finding conclusive and acceptable biochemical evidence.


ADA, Diabetes, Obesity

Full Text:



Amatruda JM, Statt MC, Welle SL. Total and resting energy expenditure in obese women reduced to ideal body weight. J Clin Invest. 1993;92:1236-42.

Flier JS. The adipocytes: storage depot or node on the energy information superhighway? Cell. 1995;80:15-8.

Dhingra V, Chatterjee A, Guleria R, Sharma R, Pandey RM, Talwar KK, Misra A. Adverse physical activity pattern in urban adolescents. J Assoc Physicians India. 2002;50:1521.

Singh RB, Bajaj S, Niaz MA, Rastogi SS, Moshiri M. Prevalence of type 2 diabetes mellitus and risk of hypertension and coronary artery disease in rural and urban population with low rates of obesity. Int J Cardiol. 1998;66:65-72.

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-53.

Spencer N, Hopkinson D, Harris H. Adenosine deaminase polymorphism in man. Ann Hum Genet. 1968;32:9-14.

Bottini E, Gloria-Bottini F. Adenosine deaminase and body mass index in non-insulin-dependent diabetes mellitus. Metabolism. 1999;48:949-51.

Kanter R, Caballero B. Global Gender Disparities in Obesity: A Review. American Society for Nutrition. Adv Nutr. 2012;3:491-8.

Kim IH, Chun H, Kwon JW. Gender differences in the effect of obesity on chronic diseases among the elderly Koreans. J Kor Med Sci. 2011;26(2):250-7.

Wei M, Gaskill SP, Haffner SM, Stern MP. Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans-a 7‐year prospective study. Obesity research. 1997 Jan;5(1):16-23.

Green A. Adenosine receptor down-regulation and insulin resistance following prolonged incubation of adipocytes with an A1 adenosine receptor agonist. J Biol Chem. 1987;262:15702-7.

Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumour necrosis factor in human adipose tissue. Regulation of obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest. 1995;95:2111-19.

Firestein GS, Boyle D, Bullough DA, Gruber HE, Sajjadi FG, Montag A, et al. Protective effect of an adenosine kinase inhibitor in septic shock. J Immunol. 1994;152:5853-9.

Adanin S, Yalovetskiy IV, Nardulli BA, Sam II AD, Jonjev ZS, Law WR. Inhibiting adenosine deaminase modulates the systemic inflammatory response syndrome in endotoxemia and sepsis. Am J Physiol Regul Integr Comp Physiol. 2002;282:R1324-32.

Mohan V. Why are Indians more prone to diabetes? J Assoc Physicians India. 2004;52:468-74.

Cronstein BN, Eberle MA, Gruber HE, Levin RI. Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci USA. 1991;88:2441-5.

Cronstein BN, Montesinos MC, Weissmann G. Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFκB. Proc Natl Acad Sci USA. 1999;96:6377-81.

Cronstein BN, Naime D, Firestein GS. The anti-inflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum. 1995;38:1040-45.

Gadangi P, Longaker M, Naime D, Levin RI, Recht PA, Montesinos MC, et al. The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. J Immunol. 1996;156:1937-41.